WILLIAM PEACOCK to Pyridones
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Pyridones.
Connection Strength
0.961
-
Reducing the hospital burden associated with the treatment of pulmonary embolism. J Thromb Haemost. 2019 05; 17(5):720-736.
Score: 0.142
-
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Stroke. 2017 08; 48(8):2142-2149.
Score: 0.126
-
Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice. Heart Lung Circ. 2018 Mar; 27(3):390-393.
Score: 0.124
-
Safety of direct oral anticoagulants: insights from postmarketing studies. Am J Emerg Med. 2016 Nov; 34(11S):9-13.
Score: 0.119
-
Safety of Direct Oral Anticoagulants: Insights from Postmarketing Studies. Am J Med. 2016 Nov; 129(11S):S41-S46.
Score: 0.119
-
Doses of apixaban and rivaroxaban prescribed in real-world United States cardiology practices compared to registration trials. Curr Med Res Opin. 2016 07; 32(7):1277-9.
Score: 0.115
-
Target-specific Oral Anticoagulants in the Emergency Department. J Emerg Med. 2016 Feb; 50(2):246-57.
Score: 0.112
-
Managing bleeding and emergency reversal of newer oral anticoagulants: a review for primary care providers. Hosp Pract (1995). 2014 Oct; 42(4):75-82.
Score: 0.104